Compare Heron Therapeutics Inc (HRTX) vs Unity Software Inc (U) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Unity Software Inc — how do they compare? Heron Therapeutics Inc trades at $0.47 (market cap $91.46M), while Unity Software Inc trades at $30.29 (market cap $13.01B). The key difference: Unity Software Inc is far larger — about 142.2× Heron Therapeutics Inc's market cap, and Unity Software Inc is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| HRTX | U | |
|---|---|---|
Market Cap | $91.46M | $13.01B |
Sector | Health | Technology |
52-Week High | $1.96 | $49.47 |
52-Week Low | $0.39 | $17.13 |
Enterprise Value | $189.36M | $13.11B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.
Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.
Unity Software (U) trades at $30.14, up 3.97% in the last session, with a bearish technical signal despite recent momentum. Revenue held at $1.85B in 2025, but net losses narrowed to -$403M, improving margins. Analysts are bullish with a $36.50 consensus target, citing AI-driven advertising potential. Cash flow strengthened with $423M from operations in 2025, though high debt and profitability challenges persist.
The stock offers upside if AI initiatives accelerate revenue growth, but risks include sustained losses and competitive pressure. With 69% buy ratings, Wall Street sees value, yet investors must weigh execution risks against the 21% discount to target.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Unity Software Inc
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC and Other Americas, of which key revenue is derived from the EMEA region. The products are used in the gaming industry, architecture and construction sector, animation industry, and designing sector.
Read more on U →
